Therakos Inc

FDA Regulatory Profile

Therakos Inc appears in FDA public data with 2 recalls, 0 510(k) clearances, 3 FDA inspections, and 0 compliance actions on record. Its most recent recall (Z-0212-2022, Class II) was initiated on October 4, 2021.

Summary

Total Recalls
2
510(k) Clearances
0
Inspections
3
Compliance Actions
0

Recent Recalls

NumberClassProductDate
Z-0212-2022Class IITHERAKOS CELLEX Photopheresis Procedural Kit PRODUCT CODE: CLXUSAOctober 4, 2021
Z-1322-2016Class IIThe THERAKOS CELLEX Photopheresis System is a photoimmune therapy. Catalog CLXUSA. Manufacturing December 21, 2015